NASDAQ

SAB Biotherapeutics, Inc. (SABS)

♥ 683 Thanks from members

Live price chart, market sentiment, and community perspectives for SAB Biotherapeutics, Inc. (NASDAQ: SABS).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Eddie J. SullivanLeadership: J. William Weir (CEO)Holder: Omaha Charitable Lead TrustHolder: Intrepid CapitalHolder: Institutional HoldersDiversitAb PlatformSAB-185Immunotherapy Solutions#SABS#SAB Biotherapeutics#NASDAQ Biotech#Human Antibodies#Immunotherapy